Pressure Bio Q1 Revenues Rise 9 Percent but Firm Warns of Cash Shortage | GenomeWeb

NEW YORK (GenomeWeb) – Pressure BioSciences said in its Form 10-Q filed with the US Securities and Exchange Commission on Friday that its revenues in Q1 2015 grew 9 percent year over year to $440,134 from $404,147. 

Product, services, and other revenues were down to $359,364 from $404,147 in Q1 2014, but grant revenues increased to $80,770 from zero in the year-ago quarter. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.